Gini Index-Based Maximum Concentration and Area Under the Curve Split Points for Analysing Adverse Event Occurrence in Bioequivalence Studies

dc.creatorTorres-García B.L., Castro-Pastrana L.I., Rodríguez-Rodríguez S., Estrada-Marín L., Cedillo-Carvallo B., Guzmán-García O., Ruíz-Argüelles A.
dc.date2020-12-11T06:40:51Z
dc.date2020-12-11T06:40:51Z
dc.date2018
dc.date.accessioned2023-07-21T20:21:48Z
dc.date.available2023-07-21T20:21:48Z
dc.identifier2-s2.0-85041838372
dc.identifierhttp://repositorio.udlap.mx/xmlui/handle/123456789/13425
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/7745548
dc.descriptionhttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85041838372&doi=10.1007%2fs40290-017-0217-3&partnerID=40&md5=2b2fa2cca6d413bf6506590388ca0c79
dc.sourcePharmaceutical Medicine
dc.titleGini Index-Based Maximum Concentration and Area Under the Curve Split Points for Analysing Adverse Event Occurrence in Bioequivalence Studies
dc.typeArticle


Este ítem pertenece a la siguiente institución